DK1893210T3 - Selektiv apoptotisk induktion i cancerceller, herunder aktivering af procaspase-3 - Google Patents
Selektiv apoptotisk induktion i cancerceller, herunder aktivering af procaspase-3 Download PDFInfo
- Publication number
- DK1893210T3 DK1893210T3 DK06771588.8T DK06771588T DK1893210T3 DK 1893210 T3 DK1893210 T3 DK 1893210T3 DK 06771588 T DK06771588 T DK 06771588T DK 1893210 T3 DK1893210 T3 DK 1893210T3
- Authority
- DK
- Denmark
- Prior art keywords
- procaspase
- activation
- cancer cells
- apoptotic induction
- selective apoptotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96466—Cysteine endopeptidases (3.4.22)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68480705P | 2005-05-26 | 2005-05-26 | |
US74387806P | 2006-03-28 | 2006-03-28 | |
US11/420,425 US20070049602A1 (en) | 2005-05-26 | 2006-05-25 | Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3 |
PCT/US2006/020910 WO2006128173A2 (en) | 2005-05-26 | 2006-05-26 | Selective apoptotic induction in cancer cells including activation of procaspase-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1893210T3 true DK1893210T3 (da) | 2020-01-13 |
Family
ID=37452994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06771588.8T DK1893210T3 (da) | 2005-05-26 | 2006-05-26 | Selektiv apoptotisk induktion i cancerceller, herunder aktivering af procaspase-3 |
Country Status (10)
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008134474A2 (en) | 2007-04-27 | 2008-11-06 | The Board Of Trustees Of The University Of Illinois | Compositions and methods including cell death inducers and procaspase activation |
US20070049602A1 (en) * | 2005-05-26 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3 |
CN106946812B (zh) | 2009-02-09 | 2020-10-09 | 伊利诺伊大学评议会 | 作为个性化抗癌药的胱天蛋白酶原活化化合物的设计、合成和评价 |
WO2010102513A1 (zh) * | 2009-03-11 | 2010-09-16 | 深圳市湘雅生物医药研究院 | 高哌嗪乙酰肼类衍生物及其制备方法和用途 |
CN101805338B (zh) * | 2010-04-06 | 2014-10-15 | 沈阳药科大学 | 噁二唑基哌嗪衍生物及其用途 |
US8916705B2 (en) * | 2011-10-14 | 2014-12-23 | The Board of Trustees of The University of Illilnois | Procaspase-activating compounds and compositions |
EP2819661B1 (en) | 2012-03-02 | 2016-11-09 | The Board of Trustees of the University of Illionis | Potent anticancer activity via dual compound activation |
MX359209B (es) * | 2012-03-06 | 2018-09-19 | Univ Illinois | Terapia de combinacion de procaspasa para gliobastoma. |
IN2014MN01945A (US07794700-20100914-C00125.png) | 2012-03-06 | 2015-07-10 | Univ Illinois | |
CN104981461B (zh) * | 2012-08-03 | 2017-09-29 | 伊利诺伊大学评议会 | 激活酶的化合物及组合物 |
CN105218399B (zh) * | 2014-05-30 | 2018-02-09 | 中国人民解放军军事医学科学院毒物药物研究所 | 一种取代乙酰肼类衍生物、其制备方法及用途 |
EP3302478B1 (en) | 2015-06-05 | 2021-11-17 | The Board of Trustees of the University of Illinois | Pac-1 combination therapy |
EP3326631B1 (en) * | 2015-07-23 | 2021-07-14 | Zhimin Wang | Compound pac-1 or salt thereof, and pharmaceutical composition comprising same |
ES2809556T3 (es) * | 2015-07-24 | 2021-03-04 | Shenzhen Zhenxing Medical Tech Co Ltd | Azina orbital-fumarato, hidrato, forma cristalina y método de preparación de los mismos |
CN105085421B (zh) * | 2015-07-24 | 2017-12-26 | 深圳市湘雅生物医药研究院 | 奥比特嗪‑富马酸盐、水合物、晶型及其制备方法 |
JP7349155B2 (ja) | 2017-11-17 | 2023-09-22 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシテイ オブ イリノイ | 二元的なmekシグナル伝達の低減によるがん治療 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2289972C (en) * | 1997-05-22 | 2011-06-07 | The Burnham Institute | Screening assays for agents that alter inhibitor of apoptosis (iap) protein regulation of caspase activity |
US6403765B1 (en) | 1998-06-16 | 2002-06-11 | Thomas Jefferson University | Truncated Apaf-1 and methods of use thereof |
US6303329B1 (en) | 1998-07-27 | 2001-10-16 | Pharmacia & Upjohn Company | Method for autoactivation of procaspase 8 |
US6110691A (en) | 2000-01-06 | 2000-08-29 | Board Of Regents, The University Of Texas System | Activators of caspases |
US6608026B1 (en) | 2000-08-23 | 2003-08-19 | Board Of Regents, The University Of Texas System | Apoptotic compounds |
WO2002048329A2 (en) | 2000-11-20 | 2002-06-20 | Idun Pharmaceuticals, Inc. | Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
WO2002069995A2 (en) * | 2001-02-16 | 2002-09-12 | Medical College Of Georgia Research Institute, Inc. | Use of trail and antiprogestins for treating cancer |
KR100439425B1 (ko) * | 2001-03-22 | 2004-07-05 | (주)바이오케어 | 잔토리졸을 포함하는 조성물 및 그 용도 |
WO2003024955A2 (en) | 2001-09-18 | 2003-03-27 | Sunesis Pharmaceuticals, Inc. | Small molecule inhibitors of caspases |
JP2006508666A (ja) * | 2002-12-10 | 2006-03-16 | オタワ ヘルス リサーチ インスティテュート | カスパーゼ3活性調節による幹細胞分化の調節 |
WO2004066958A2 (en) | 2003-01-30 | 2004-08-12 | The Trustees Of Princeton University | Caspase-9:bir3 domain of xiap complexes and methods of use |
US20070049602A1 (en) * | 2005-05-26 | 2007-03-01 | The Board Of Trustees Of The University Of Illinois | Selective Apoptotic Induction in Cancer Cells Including Activation of Procaspase-3 |
-
2006
- 2006-05-25 US US11/420,425 patent/US20070049602A1/en not_active Abandoned
- 2006-05-26 AU AU2006251978A patent/AU2006251978A1/en not_active Abandoned
- 2006-05-26 JP JP2008513829A patent/JP5513741B2/ja active Active
- 2006-05-26 ES ES06771588T patent/ES2763156T3/es active Active
- 2006-05-26 EP EP13166147.2A patent/EP2634581A1/en not_active Withdrawn
- 2006-05-26 EP EP06771588.8A patent/EP1893210B1/en active Active
- 2006-05-26 EP EP13166145.6A patent/EP2659884A3/en not_active Withdrawn
- 2006-05-26 DK DK06771588.8T patent/DK1893210T3/da active
- 2006-05-26 WO PCT/US2006/020910 patent/WO2006128173A2/en active Application Filing
- 2006-05-26 CA CA002610366A patent/CA2610366A1/en not_active Abandoned
- 2006-05-26 MX MX2007014843A patent/MX2007014843A/es not_active Application Discontinuation
-
2007
- 2007-11-25 IL IL187603A patent/IL187603A0/en unknown
-
2012
- 2012-11-15 JP JP2012251584A patent/JP5907852B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2610366A1 (en) | 2006-11-30 |
JP5907852B2 (ja) | 2016-04-26 |
JP5513741B2 (ja) | 2014-06-04 |
JP2013100285A (ja) | 2013-05-23 |
EP1893210B1 (en) | 2019-10-02 |
EP2659884A3 (en) | 2014-10-01 |
AU2006251978A1 (en) | 2006-11-30 |
WO2006128173A2 (en) | 2006-11-30 |
WO2006128173A3 (en) | 2007-05-24 |
EP2634581A1 (en) | 2013-09-04 |
ES2763156T3 (es) | 2020-05-27 |
US20070049602A1 (en) | 2007-03-01 |
MX2007014843A (es) | 2008-02-14 |
EP2659884A2 (en) | 2013-11-06 |
EP1893210A4 (en) | 2010-09-01 |
EP1893210A2 (en) | 2008-03-05 |
IL187603A0 (en) | 2008-03-20 |
JP2008545718A (ja) | 2008-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1893210T3 (da) | Selektiv apoptotisk induktion i cancerceller, herunder aktivering af procaspase-3 | |
DK3514565T3 (da) | Tilvejebringelse af forbedret positionslokalisering i trådløs kommunikation | |
DE602005022897D1 (de) | Piperidinylamino-thienoä2,3-dü-pyrimidinverbindungen | |
DE602005021720D1 (de) | Messer | |
DE602005026205D1 (de) | Rasiersystem | |
DE502005007723D1 (de) | 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactone, | |
FR2872704B1 (fr) | Pluritherapie contre le cancer | |
DE602005004015D1 (de) | Zerkleinerer | |
FI20055175A0 (fi) | Radioyhteysmenettely CDMA-pohjaisessa viestintäjärjestelmässä | |
FI20045182A0 (fi) | Tiedonsiirto UMTS järjestelmässä | |
FI20045190A (fi) | Energiantuotantojärjestely | |
AT8010U3 (de) | Denkmal, insbesondere grabmal | |
FI20050916A0 (fi) | Järjestely lastuavassa työkalussa | |
DK1720557T3 (da) | Hurtig-opløselig, smagsmaskeret tablet | |
DE112005002004A5 (de) | Messer | |
FR2876232B3 (fr) | Convertisseur-thermo-electrique solaire | |
NO20052022D0 (no) | MultiEnergiFanger | |
DE602006007259D1 (de) | Schneidevorrichtung | |
EE00608U1 (et) | Dokumendisahtel | |
FI20045499A0 (fi) | Järjestely oskillointilaitteessa | |
FI20050834A0 (fi) | Säädettävä pankkokiinnitys | |
ES1059189Y (es) | Bolsillo. | |
SE0400769D0 (sv) | Stereoenheten, KTS Super Power | |
BR8300904Y1 (pt) | disposição introduzida em destocador. | |
BRMU8501539Y1 (pt) | disposição introduzida em discos planos recortados. |